KIMBERLY GRISANTI: Open Payments
NPI 1073198479 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 41 payments from 13 companies in 2025. Trend: 2023 $1,135 · 2024 $1,013 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $309 |
| Madrigal Pharmaceuticals | 2 | $273 |
| Janssen Biotech, Inc. | 11 | $242 |
| Phathom Pharmaceuticals, Inc. | 2 | $138 |
| GENZYME CORPORATION | 3 | $65 |
| PFIZER INC. | 3 | $57 |
| Gilead Sciences, Inc. | 3 | $56 |
| Novo Nordisk Inc | 1 | $25 |
| Celltrion USA Inc. | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, VOQUEZNA, RINVOQ, DUPIXENT, VELSIPITY, Wegovy.
Industry payments across FL — which companies pay providers there.
